Breast cancer is commonly stratified into molecular subtypes identified by immunohistochemistry for the presence of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu) [2]. This evidence concerns the gene ERBB2 and breast cancer.